RT-signup

Products

Sanofi Pasteur's Fluzone Quadrivalent helps protect adults and children as young as six months old against influenza B strain. The treatment is the newest addition to the company's "Fluzone" line of influenza vaccines.

Read more

There may be a cost savings for hospitals using Surfaxin, due to the reduced rate of reintubation among preterm infants, according to manufacturer Discovery Labs.

Read more

Three group purchasing agreements with Kimberly-Clark will provide specially negotiated pricing and terms for nearly 100,000 hospitals and care sites within the Premier Healthcare Alliance network.

Read more

The new noninvasive monitoring device, developed in conjunction with Mayo Clinic, remotely detects and monitors non-lethal cardiac arrhythmias while allowing patients freedom and mobility.

Read more

The company’s Nellcor pulse oximeters are the market’s only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61, according to Covidien.

Read more

The Lung Volume Reduction Coil, created by PneumRx, is designed to improve lung function, exercise capacity and quality of life for people with advanced emphysema.

Read more

GlaxoSmithKline and Theravance Inc’s BREO ELLIPTA, an inhaled long-term, once-daily treatment for airflow obstruction in COPD patients, has received FDA approval.

Read more

Page 1 of 14